Gateway Investment Advisers LLC Takes Position in DaVita Inc. (NYSE:DVA)

Gateway Investment Advisers LLC purchased a new stake in shares of DaVita Inc. (NYSE:DVA) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 1,580 shares of the company’s stock, valued at approximately $218,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Newbridge Financial Services Group Inc. bought a new position in shares of DaVita during the 4th quarter valued at $30,000. Principal Securities Inc. acquired a new position in DaVita in the 4th quarter valued at $37,000. GAMMA Investing LLC acquired a new position in DaVita in the 4th quarter valued at $60,000. Quest Partners LLC acquired a new position in DaVita in the 4th quarter valued at $74,000. Finally, Mather Group LLC. acquired a new position in DaVita in the 1st quarter valued at $118,000. Institutional investors own 90.12% of the company’s stock.

Insider Activity

In other news, Director Barbara J. Desoer sold 5,030 shares of DaVita stock in a transaction dated Friday, May 10th. The shares were sold at an average price of $138.81, for a total transaction of $698,214.30. Following the sale, the director now directly owns 10,954 shares in the company, valued at approximately $1,520,524.74. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 2.00% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the stock. StockNews.com lowered shares of DaVita from a “strong-buy” rating to a “buy” rating in a research note on Saturday, June 8th. Truist Financial raised their target price on shares of DaVita from $135.00 to $150.00 and gave the company a “hold” rating in a research note on Wednesday, May 15th. Finally, Barclays raised their target price on shares of DaVita from $133.00 to $150.00 and gave the company an “equal weight” rating in a research note on Monday, May 6th. Two analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, DaVita has an average rating of “Moderate Buy” and an average target price of $144.67.

DaVita Stock Performance

NYSE DVA opened at $142.16 on Thursday. The company has a debt-to-equity ratio of 7.95, a current ratio of 1.43 and a quick ratio of 1.37. The firm has a market capitalization of $12.47 billion, a price-to-earnings ratio of 16.15, a P/E/G ratio of 1.09 and a beta of 0.96. The company’s fifty day moving average is $139.19 and its two-hundred day moving average is $126.29. DaVita Inc. has a 52-week low of $71.51 and a 52-week high of $147.93.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Thursday, May 2nd. The company reported $2.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.95 by $0.43. DaVita had a net margin of 6.61% and a return on equity of 68.52%. The company had revenue of $3.07 billion for the quarter, compared to analyst estimates of $3.03 billion. During the same period last year, the business posted $1.58 EPS. The business’s quarterly revenue was up 6.9% on a year-over-year basis. Equities research analysts forecast that DaVita Inc. will post 9.62 EPS for the current year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.